Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
[1-hydroxy-2-(1,1':3',1''-terphenyl-3-yloxy)ethane-1,1-diyl]bis(phosphonic acid) is an experimental small molecule bisphosphonate compound with the molecular formula C20H20O8P2 and a molecular weight of approximately 450.32 Da. It is structurally related to other bisphosphonates and contains a terphenyl group linked via an ether bond to a hydroxyethane-bisphosphonic acid core. While its precise mechanism of action has not been fully characterized in clinical settings, bisphosphonates typically act by inhibiting enzymes involved in bone resorption or isoprenoid biosynthesis pathways such as geranylgeranyl pyrophosphate synthase (GGPPS). This compound has been studied primarily at the preclinical or experimental level and does not have established therapeutic indications or commercial development status[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on [1-hydroxy-2-(1,1':3',1''-terphenyl-3-yloxy)ethane-1,1-diyl]bis(phosphonic acid).